USNA (USANA Health Sciences Inc) Stock Analysis - SEC Filings

USANA Health Sciences Inc (USNA) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, USNA trades at $18.07 with a market cap of $333.07M and a P/E ratio of 8.25. USNA moved +4.09% today. Year to date, USNA is -4.58%; over the trailing twelve months it is -39.59%. Its 52-week range spans $16.60 to $41.84. Rallies surfaces USNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find USNA SEC filings?

Rallies organizes USNA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

USNA Key Metrics

Key financial metrics for USNA
MetricValue
Price$18.07
Market Cap$333.07M
P/E Ratio8.25
EPS$2.20
Dividend Yield0.00%
52-Week High$41.84
52-Week Low$16.60
Volume37
Avg Volume0
Revenue (TTM)$854.50M
Net Income$42.06M
Gross Margin81.13%

Latest USNA News

Recent USNA Insider Trades

  • Foukas Joshua sold 3.79K (~$75.14K) on May 7, 2026.
  • FULLER GILBERT A sold 1.06K (~$17.99K) on Mar 20, 2026.
  • Benedict Peter sold 4.55K (~$88.26K) on Mar 3, 2026.

USNA Analyst Consensus

USNA analyst coverage data. Average price target: $0.00.

Common questions about USNA

Where can I find USNA SEC filings?
Rallies organizes USNA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show USNA 10-K and 10-Q filings?
Rallies organizes USNA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is USNA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for USNA. It does not provide personalized investment advice.
USNA

USNA